People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 4Tech, Inc. | — | Biotechnology | Series B | $62.3M | $1.1B | 2011 |
| Viseon, Inc. | — | Other Technology | Series B | $32.0M | $20.0M | 2020 |
Benjamin C. Tsai at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin C. Tsai on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael R. Henson | 1 | 9 |
| Jeffrey J. Valko | 1 | 4 |
| Lawrence C. Best | 1 | 4 |
| Benjamin Tsai | 1 | 4 |
| Rudi Marien | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Eric Le Royer | 1 | 1 |
| Carine Schorochoff | 1 | 1 |
| Jill Tracy Pearson | 1 | 1 |
| Peter G Davis | 1 | 1 |
| Ron R. Bache | 1 | 1 |
| Rachel Tracy Reginato | 1 | 1 |
| Peter C. Davis | 1 | 1 |
| Hugo C Vanerman | 1 | 1 |
| Paul C Van Den Heuvel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.